Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: a randomized open-label trial

被引：0

作者：

Young-Il Kim

Jong Yeul Lee

Chan Gyoo Kim

Boram Park

Jin Young Park

Il Ju Choi

机构：

[1] National Cancer Center,Center for Gastric Cancer

[2] National Cancer Center,Biostatistics Collaboration Team, Research Core Center, Research Institute

[3] International Agency for Research on Cancer,Prevention and Implementation Group

来源：

BMC Gastroenterology | / 21卷

关键词：

Quadruple therapy; Triple therapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 137 条

[1]

Malfertheiner P(2017)Management of Gut 66 6-30

[2]

Megraud F(2017) infection-the Maastricht V/Florence Consensus Report Am J Gastroenterol 112 212-239

[3]

O'Morain CA(1998)ACG Clinical guideline: treatment of Korean J Gastroenterol 32 275-289

[4]

Gisbert JP(2009) infection Korean J Gastroenterol 54 269-278

[5]

Kuipers EJ(2014)Diagnosis and treatment of J Gastroenterol Hepatol 29 1371-1386

[6]

Axon AT(2019) infection in Korea Helicobacter 24 e12646-1009

[7]

Chey WD(2019)Diagnosis and treatment guidelines for Helicobacter 24 e12592-713

[8]

Leontiadis GI(2019) infection in Korea Helicobacter 24 e12660-540

[9]

Howden CW(2015)Guidelines for the diagnosis and treatment of J Korean Med Sci 30 1001-186.e3

[10]

Moss SF(2014) infection in Korea, 2013 revised edition J Korean Med Sci 29 704-563